Aatiqah Aziz

Ms. Aatiqah Aziz

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MVMAYUR VIRARKAR
MAYUR VIRARKAR
SJSanaz Javadi
Sanaz Javadi
AAAatiqah Aziz
Aatiqah Aziz
JSJia Sun
Jia Sun
RIRevathy B. Iyer
Revathy B. Iyer
PBPriya Bhosale
Priya Bhosale
Objective: This study aimed to compare the diagnostic accuracy of whole-body PET/MR imaging and contrast-enhanced CT for detecting metastatic disease in patients undergoing surgical resection, using pathology as the reference standard. Materials and Methods: Nineteen patients with suspected metastatic involvement (including four who received neoadjuvant therapy before surgery) underwent both FDG PET/MR and contrast-enhanced CT scans. Imaging was reviewed for metastases at defined sites (e.g., perihepatic region, hepatic parenchyma, mesentery, bowel serosa, colon surface, and nodal basins). Findings on each modality were compared to surgical pathology results per site. Sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) were calculated for PET/MR and CT, with pathology as the reference standard. Results: Overall, PET/MR achieved approximately 55.5% sensitivity, 89.5% specificity, 82.5% accuracy, 57.6% positive predictive value (PPV), and 88.6% negative predictive value (NPV). In contrast, CT demonstrated 75.0% sensitivity, 72.3% specificity, 72.9% accuracy, 42% PPV, and 91.5% NPV. No significant correlations were observed between semi-quantitative PET/MR measures, such as SUV or MR ADC values, and patient survival outcomes; therefore, these metrics were excluded from further analysis. Notably, PET/MR imaging findings changed clinical management in 3/6 chemotherapy patients. PET/MR demonstrated greater sensitivity in detecting nodal metastases, 75% compared to CT (25%), and identified small bowel serosal lesions in 1 of 1 case (100% sensitivity) versus none with CT. CT showed slightly higher specificity (81%) for colon serosal involvement than PET/MR (75%). Conclusions: CT demonstrates higher sensitivity, whereas PET/MR offers greater specificity and negative predictive value. When used together, the two modalities may provide a more reliable and comprehensive assessment of metastatic disease.

24 October 2023 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
PDF file
MFMichael Frumovitz
Michael Frumovitz
AMAjaykumar C Morani
Ajaykumar C Morani
AAAatiqah Aziz
Aatiqah Aziz
AJAnuja Jhingran
Anuja Jhingran
PRPreetha Ramalingam
Preetha Ramalingam
PBPriya Bhosale
Priya Bhosale
Objective To determine the optimal imaging modality for women with high-grade neuroendocrine carcinoma of the cervix. Methods Women with high-grade neuroendocrine carcinoma of the cervix who had undergone a computed tomography (CT) scan and combined positron emission tomography with computed tomography (PET/CT) scan within 4 weeks of each other were identified from the NeCTuR Cervical Tumor Registry. One radiologist reviewed all CT scans, and another radiologist reviewed all PET/CT scans. The radiologists denoted the presence or absence of disease at multiple sites. Each radiologist was blinded to prior reports, patient outcomes, and the readings of the other radiologist. With findings on PET/CT used as the gold standard, sensitivity, specificity, and accuracy were calculated for CT scans. Results Fifty matched CT and PET/CT scans were performed in 41 patients. For detecting primary disease in the cervix, CT scan had a sensitivity of 85%, a specificity of 46%, and an accuracy of 74%. For detecting disease spread to the liver, CT scan had a sensitivity of 80%, a specificity of 89%, and an accuracy of 86%. For detecting disease spread to the lung, CT had a sensitivity of 89%, a specificity of 68%, and an accuracy of 77%. Of the 14 patients who had scans for primary disease work-up, 4 (29%) had a change in their treatment plan due to the PET/CT scan. Had treatment been prescribed on the basis of the CT scan alone, 2 patients would have been undertreated, and 2 would have been overtreated. Conclusion A CT scan is inferior to a PET/CT scan in assessment of metastatic disease in women with high-grade neuroendocrine carcinoma of the cervix. Almost one-third of patients with newly diagnosed high-grade neuroendocrine cervical cancer would have received incorrect therapy had treatment planning been based solely on a CT scan. We recommend a PET/CT scan for both initial work-up and surveillance in women with high-grade neuroendocrine carcinoma of the cervix.

29 October 2025 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
TDTaher Daoud
Taher Daoud
RSRitu Shah
Ritu Shah
SYSatyanarayana Yaramala
Satyanarayana Yaramala
AGAnjali Verma Gupta
Anjali Verma Gupta
AAAatiqah Aziz
Aatiqah Aziz
PBPriya Bhosale
Priya Bhosale


27 November 2024 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
MVMAYUR VIRARKAR
MAYUR VIRARKAR
AAAatiqah Aziz
Aatiqah Aziz
JSJia Sun
Jia Sun
AMAjaykumar C Morani
Ajaykumar C Morani
MFMichael Frumovitz
Michael Frumovitz
PBPriya Bhosale
Priya Bhosale

21 July 2025 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
AAAatiqah Aziz
Aatiqah Aziz
LKLynne M. Koweek
Lynne M. Koweek